Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-23

Clinical Trial Update: Topiramate for the Treatment of Methamphetamine Dependence - 1 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating topiramate for methamphetamine use disorder has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Methamphetamine | Phase 2 | Status: COMPLETED | Results posted: 2017-02-23